Network Analysis for the Discovery of Common Oncogenic Biomarkers in Liver Cancer Experimental Models
Hepatocellular carcinoma (HCC) is a malignancy marked by heterogeneity. This study aimed to discover target molecules for potential therapeutic efficacy that may encompass HCC heterogeneity. In silico analysis using published datasets identified 16 proto-oncogenes as potential pharmacological target...
Main Authors: | Loraine Kay D. Cabral, Pablo J. Giraudi, Gianluigi Giannelli, Francesco Dituri, Roberto Negro, Claudio Tiribelli, Caecilia H. C. Sukowati |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/342 |
Similar Items
-
PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma
by: Caecilia Sukowati, et al.
Published: (2023-08-01) -
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
by: Loraine Kay D. Cabral, et al.
Published: (2020-06-01) -
Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle
by: Caecilia Sukowati, et al.
Published: (2022-09-01) -
The Relevance of <i>SOCS1</i> Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
by: Loraine Kay D. Cabral, et al.
Published: (2021-10-01) -
Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma
by: Caecilia H. C. Sukowati, et al.
Published: (2021-01-01)